{"id":13799,"date":"2023-12-20T15:10:41","date_gmt":"2023-12-20T15:10:41","guid":{"rendered":"https:\/\/nhcoa.org\/es\/?p=13799"},"modified":"2023-12-20T15:10:42","modified_gmt":"2023-12-20T15:10:42","slug":"learning-more-about-the-new-covid-19-treatments","status":"publish","type":"post","link":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","title":{"rendered":"Learning more about the new COVID-19 treatments"},"content":{"rendered":"\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-1024x576.png\" alt=\"\" class=\"wp-image-13800\" style=\"width:550px\" srcset=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-980x551.png 980w, https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53-480x270.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-a407a500325a86e834d84446a9ef0ce7 wp-block-paragraph\" style=\"font-size:15px\">Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. <strong>Veklury (Remdesivir) <\/strong>is an antiviral drug meant for <strong>adults and certain pediatric patients<\/strong> infected with COVID-19, and is administered <strong>intravenously (IV drip)<\/strong> both in hospitals and outpatient settings. In tandem with the introduction of <strong>Veklury<\/strong>, the FDA has also approved immune modulators, <strong>Olumiant (Baricitinib)<\/strong> and <strong>Actemra (Tocilizumab)<\/strong>, which will only be used for certain <strong>hospitalized adults with COVID-19<\/strong>, and not in outpatient settings.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-57ef60bf3429c3c8048afd9f6534df87 wp-block-paragraph\" style=\"font-size:15px\">The antiviral oral treatment <strong>Paxlovid (Nirmatrelvir tablets and Ritonavir tablets) <\/strong>has also been approved to treat COVID-19 in adults, both to <strong>prevent the infection entirely and to treat eligible non-hospitalized patients <\/strong>who are experiencing mild to moderate symptoms.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-8338ce7e1362f15a04dd28ad45bc686a wp-block-paragraph\" style=\"font-size:15px\">If you have been diagnosed with COVID-19 and have symptoms, contact your healthcare professional to determine if any of these treatments are right for you. R<strong>emember that prevention and early treatment can help improve patient outcomes, reduce stress on healthcare facilities and even save lives.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-6b4d768e8931b097cbb7b75fb7baaf7b wp-block-paragraph\" style=\"font-size:15px\">However, <strong>while these treatments can be necessary for eligible patients, they are not a substitute for COVID-19 vaccination<\/strong>. These biologics and therapeutic drugs are helpful, especially in treating the infection, and can aid in prevention, but individuals are <strong>still advised to receive the COVID-19 vaccine and available booster doses<\/strong>. Find available COVID-19 vaccine and booster doses near you at <a href=\"http:\/\/vaccines.gov\" target=\"_blank\" rel=\"noreferrer noopener\">vaccines.gov<\/a>.<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-0933d4b2cd4c58e2694bc268be3b9ba8 wp-block-paragraph\" style=\"font-size:15px\">The FDA continues to work with developers, researchers, manufacturers, the National Institutes of Health (NIH), and other partners to in the development and availability of therapeutic drugs and biologics to prevent or treat COVID-19. <strong>Check if a drug is FDA-approved by searching their database of approved drugs: <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/\" target=\"_blank\" rel=\"noreferrer noopener\">Drugs@FDA database<\/a>.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-84638570d40f5747133fc90355916a5f wp-block-paragraph\" style=\"font-size:15px\">Available treatment for COVID-19 is constantly evolving into forms and products that better respond to the virus. The products listed below are not currently licensed in the U.S. because they are not as effective against the currently circulating SARS-CoV-2 variants. Suppliers with existing stocks of these products are encouraged to hold on to them. <strong>Staying knowledgeable on these possible treatments is important, should they prove more effective in the future, against new strains of COVID-19.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-7323498589767b86b25406f8bdc9e2b0 wp-block-paragraph\" style=\"font-size:15px\">Treatments awaiting FDA approval include:<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-9d3cac5e73da59a20db7b81d996b0e13 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Evusheld<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-8bc4fb2f275dec1603d0e1f101f932be wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bebtelovimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-c890c08fe868c6a4121c22ead77917e8 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Sotrovimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-7d6619bd047e624e4173911449b0d2fd wp-block-paragraph\" style=\"font-size:15px\">\u2714 REGEN-COV<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-0115ada469fac4544f8c715d9803408d wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bamlanivimab\/etesevimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-977faa0e7b5680a156b855dedd852379 wp-block-paragraph\" style=\"font-size:15px\">\u2714 Bamlanivimab<\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-4e234e3d89c06967645eada191db94d9 wp-block-paragraph\" style=\"font-size:15px\">The Administration for Strategic Preparedness and Response (ASPR) offers summaries of key information on all outpatient therapies currently licensed or approved in the United States for COVID-19. <strong>Visit the link below for the latest updates from ASPR: <a href=\"https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx<\/a>.<\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-61e86a58bf09354602fdf196d2d28532 wp-block-paragraph\" style=\"font-size:15px\"><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-fea21977aadf1edec806e331ecd4073e wp-block-paragraph\" style=\"font-size:15px\"><strong>References: <\/strong><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-373526fb079c5b8cff1b06c4433a18f5 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/covidvaccineproject.org\/treatments\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/covidvaccineproject.org\/treatments\/ <\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-650dd5ab36a1b598d74e9c7d969e08e2 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Pages\/default.aspx <\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-b366bbf662f67d9aa8503bc94c686d92 wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/aspr.hhs.gov\/COVID-19-Therapeutics\/Side-by-Side-Overview\/Pages\/default.aspx<\/a><\/p>\n\n\n\n<p class=\"has-black-color has-text-color has-link-color wp-elements-a08259e8f830abb4e24f0d745341a70c wp-block-paragraph\" style=\"font-size:15px\"><a href=\"https:\/\/www.fda.gov\/consumers\/articulos-para-el-consumidor-en-espanol\/conozca-sus-opciones-de-tratamiento-contra-el-covid19#:~:text=%C2%BFQu%C3%A9%20tratamientos%20est%C3%A1n%20disponibles%20contra,entornos%20hospitalarios%20como%20no%20hospitalarios.\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.fda.gov\/consumers\/articulos-para-el-consumidor-en-espanol\/conozca-sus-opciones-de-tratamiento-contra-el-covid19#:~:text=%C2%BFQu%C3%A9%20tratamientos%20est%C3%A1n%20disponibles%20contra,entornos%20hospitalarios%20como%20no%20hospitalarios.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":13800,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"yes","footnotes":""},"categories":[9],"tags":[],"class_list":["post-13799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Learning more about the new COVID-19 treatments - NHCOA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Learning more about the new COVID-19 treatments - NHCOA\" \/>\n<meta property=\"og:description\" content=\"Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"NHCOA\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-20T15:10:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-20T15:10:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"nhcoa_media\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"nhcoa_media\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"},\"author\":{\"name\":\"nhcoa_media\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"headline\":\"Learning more about the new COVID-19 treatments\",\"datePublished\":\"2023-12-20T15:10:41+00:00\",\"dateModified\":\"2023-12-20T15:10:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"},\"wordCount\":466,\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Blog-header-53.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\",\"name\":\"Learning more about the new COVID-19 treatments - NHCOA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Blog-header-53.png\",\"datePublished\":\"2023-12-20T15:10:41+00:00\",\"dateModified\":\"2023-12-20T15:10:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/learning-more-about-the-new-covid-19-treatments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Learning more about the new COVID-19 treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/\",\"name\":\"NHCOA\",\"description\":\"Improving lives of hispanic and latino older adults.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/#\\\/schema\\\/person\\\/af97334cbd12a949fea7291405d4a890\",\"name\":\"nhcoa_media\",\"url\":\"https:\\\/\\\/nhcoa.org\\\/es\\\/author\\\/nhcoa_media\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Learning more about the new COVID-19 treatments - NHCOA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Learning more about the new COVID-19 treatments - NHCOA","og_description":"Recently, the US Food and Drug Administration (FDA) approved new antiviral drugs for the treatment of the COVID-19 virus. Veklury (Remdesivir) is an antiviral drug meant for adults and certain pediatric patients infected with COVID-19, and is administered intravenously (IV drip) both in hospitals and outpatient settings. In tandem with the introduction of Veklury, the [&hellip;]","og_url":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","og_site_name":"NHCOA","article_published_time":"2023-12-20T15:10:41+00:00","article_modified_time":"2023-12-20T15:10:42+00:00","og_image":[{"width":1600,"height":900,"url":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","type":"image\/png"}],"author":"nhcoa_media","twitter_card":"summary_large_image","twitter_misc":{"Written by":"nhcoa_media","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#article","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"},"author":{"name":"nhcoa_media","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"headline":"Learning more about the new COVID-19 treatments","datePublished":"2023-12-20T15:10:41+00:00","dateModified":"2023-12-20T15:10:42+00:00","mainEntityOfPage":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"},"wordCount":466,"image":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","url":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/","name":"Learning more about the new COVID-19 treatments - NHCOA","isPartOf":{"@id":"https:\/\/nhcoa.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"image":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/nhcoa.org\/es\/wp-content\/uploads\/2023\/12\/Blog-header-53.png","datePublished":"2023-12-20T15:10:41+00:00","dateModified":"2023-12-20T15:10:42+00:00","author":{"@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890"},"breadcrumb":{"@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nhcoa.org\/es\/learning-more-about-the-new-covid-19-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhcoa.org\/es\/"},{"@type":"ListItem","position":2,"name":"Learning more about the new COVID-19 treatments"}]},{"@type":"WebSite","@id":"https:\/\/nhcoa.org\/es\/#website","url":"https:\/\/nhcoa.org\/es\/","name":"NHCOA","description":"Improving lives of hispanic and latino older adults.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhcoa.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/nhcoa.org\/es\/#\/schema\/person\/af97334cbd12a949fea7291405d4a890","name":"nhcoa_media","url":"https:\/\/nhcoa.org\/es\/author\/nhcoa_media\/"}]}},"_links":{"self":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/comments?post=13799"}],"version-history":[{"count":1,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799\/revisions"}],"predecessor-version":[{"id":13803,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/posts\/13799\/revisions\/13803"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media\/13800"}],"wp:attachment":[{"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/media?parent=13799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/categories?post=13799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhcoa.org\/es\/wp-json\/wp\/v2\/tags?post=13799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}